SE8605216D0 - NOVEL MEDICINAL USE - Google Patents

NOVEL MEDICINAL USE

Info

Publication number
SE8605216D0
SE8605216D0 SE8605216A SE8605216A SE8605216D0 SE 8605216 D0 SE8605216 D0 SE 8605216D0 SE 8605216 A SE8605216 A SE 8605216A SE 8605216 A SE8605216 A SE 8605216A SE 8605216 D0 SE8605216 D0 SE 8605216D0
Authority
SE
Sweden
Prior art keywords
medicinal use
novel medicinal
novel
salt
phoscarnet
Prior art date
Application number
SE8605216A
Other languages
Swedish (sv)
Other versions
SE8605216L (en
Inventor
Bo G Danielson
Bengt Fellstrom
Bjorn Wikstrom
Bo F Oberg
Original Assignee
Bo G Danielson
Bengt Fellstrom
Bjorn Wikstrom
Bo F Oberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bo G Danielson, Bengt Fellstrom, Bjorn Wikstrom, Bo F Oberg filed Critical Bo G Danielson
Priority to SE8605216A priority Critical patent/SE8605216L/en
Publication of SE8605216D0 publication Critical patent/SE8605216D0/en
Publication of SE8605216L publication Critical patent/SE8605216L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/662Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3869Polyphosphonic acids containing carboxylic acid or carboxylic acid derivative substituents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A sufficient quantity of phoscarnet acid (or a conceivable salt) is administered. Pref. the trisodium salt is used.
SE8605216A 1986-12-04 1986-12-04 NEW MEDICAL USE SE8605216L (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SE8605216A SE8605216L (en) 1986-12-04 1986-12-04 NEW MEDICAL USE

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8605216A SE8605216L (en) 1986-12-04 1986-12-04 NEW MEDICAL USE

Publications (2)

Publication Number Publication Date
SE8605216D0 true SE8605216D0 (en) 1986-12-04
SE8605216L SE8605216L (en) 1988-06-05

Family

ID=20366522

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8605216A SE8605216L (en) 1986-12-04 1986-12-04 NEW MEDICAL USE

Country Status (1)

Country Link
SE (1) SE8605216L (en)

Also Published As

Publication number Publication date
SE8605216L (en) 1988-06-05

Similar Documents

Publication Publication Date Title
NO882472D0 (en) PROCEDURE FOR THE PREPARATION OF PEPTID DRILL ACID INHIBITORS FOR TRYP SIMILAR PROTASES.
NO861331L (en) PROCEDURE FOR THE PREPARATION OF A HYALURONIC ACID SALT.
NO882732L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
NZ221424A (en) Pharmaceutical compositions contaipyrimidines
NO901372D0 (en) PROCEDURE FOR THE MANUFACTURE OF MEDICINE BASES.
FI883487A (en) DNA clone of human tissue factor inhibitor
NO871295D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
DE3777791D1 (en) USED BLOOD PRESSURE CUFF.
NO870049D0 (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
NO863373D0 (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE AMINO ACID DERIVATIVES.
NO874850D0 (en) PROCEDURE FOR THE PREPARATION OF BENZOTIADIAZINE COMPOUNDS AND PHARMACEUTICAL ACCEPTABLE SALTS THEREOF.
NO870866L (en) PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC COMBINATION PREPARATION.
DK473088D0 (en) USE OF 2-AMINO-6-TRIFLUORMETHOXYBENZOTHIAZOL FOR THE PREPARATION OF A MEDICINE
DK473288D0 (en) USE OF 2-AMINO-6-TRIFLUORMETHOXYBENZOTHIAZOL FOR THE PREPARATION OF A MEDICINE
SE8605216D0 (en) NOVEL MEDICINAL USE
BG90414A (en) 2-AZABICYCLO (2,2,1)-HEPT-5-EN-2-ACETIC ACID AND ITS DERIVATIVES, METHOD OF PREPARATION AND THEIR APPLICATION
ATE75610T1 (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HIGH BLOOD PRESSURE.
NO893326L (en) PROCEDURE FOR THE NEUTRALIZATION OF SULVIC ACID CONTAINING ZINCIONS.
IT8621988A0 (en) PROCEDURE FOR THE PREPARATION OF 5-AMINOOROTIC ACID.
NO164099C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2-CHLORNICERGOLIN AND ACID ADDITION SALTS THEREOF.
DK160388D0 (en) TERT-BUTYLAMINO-3- (PHENYL-2'-PHENOXY) -1-PROPANOL-2 AND ACID ADDITION SALTS THEREOF USED AS A THERAPEUTIC ACTIVE SUBSTANCE
IT8519776A0 (en) PREPARATION FOR THE EXTERNAL TREATMENT OF HEMORRHOIDS.
DK378887D0 (en) USE OF 5-AMINOSALICYLIC ACID (5-ASA) FOR THE PREPARATION OF A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF CATARACTER
ATE70971T1 (en) PROMOTION OF HEALING OF MENISCIAL TISSUE.
NO162239C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BETA-CARBOLIN-3-CARBOXYLIC ACID DERIVATIVES.